These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28012583)

  • 1. NKT cells in leishmaniasis.
    Zamora-Chimal J; Hernández-Ruiz J; Becker I
    Immunobiology; 2017 Apr; 222(4):641-646. PubMed ID: 28012583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway.
    Zamora-Chimal J; Fernández-Figueroa EA; Ruiz-Remigio A; Wilkins-Rodríguez AA; Delgado-Domínguez J; Salaiza-Suazo N; Gutiérrez-Kobeh L; Becker I
    Immunobiology; 2017 Feb; 222(2):454-462. PubMed ID: 27523746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania species-dependent functional duality of toll-like receptor 2.
    Jafarzadeh A; Nemati M; Sharifi I; Nair A; Shukla D; Chauhan P; Khorramdelazad H; Sarkar A; Saha B
    IUBMB Life; 2019 Nov; 71(11):1685-1700. PubMed ID: 31329370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis.
    Yang JQ; Zhou Y; Singh RR
    J Immunol Res; 2016; 2016():2395645. PubMed ID: 27563682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to master the host immune system? Leishmania parasites have the solutions!
    Rossi M; Fasel N
    Int Immunol; 2018 Mar; 30(3):103-111. PubMed ID: 29294040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis.
    Karmakar S; Bhaumik SK; Paul J; De T
    PLoS Pathog; 2012; 8(4):e1002646. PubMed ID: 22511870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load.
    da Fonseca-Martins AM; Ramos TD; Pratti JES; Firmino-Cruz L; Gomes DCO; Soong L; Saraiva EM; de Matos Guedes HL
    Sci Rep; 2019 Dec; 9(1):20275. PubMed ID: 31889072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach.
    Krijgsman D; Hokland M; Kuppen PJK
    Front Immunol; 2018; 9():367. PubMed ID: 29535734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania mexicana lipophosphoglycan activates ERK and p38 MAP kinase and induces production of proinflammatory cytokines in human macrophages through TLR2 and TLR4.
    Rojas-Bernabé A; Garcia-Hernández O; Maldonado-Bernal C; Delegado-Dominguez J; Ortega E; Gutiérrez-Kobeh L; Becker I; Aguirre-Garcia M
    Parasitology; 2014 May; 141(6):788-800. PubMed ID: 24512642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of dendritic cell function by Leishmania parasites.
    Soong L
    J Immunol; 2008 Apr; 180(7):4355-60. PubMed ID: 18354154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8(+)NKT-like cells regulate the immune response by killing antigen-bearing DCs.
    Wang C; Liu X; Li Z; Chai Y; Jiang Y; Wang Q; Ji Y; Zhu Z; Wan Y; Yuan Z; Chang Z; Zhang M
    Sci Rep; 2015 Sep; 5():14124. PubMed ID: 26369936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.
    Kovats S; Turner S; Simmons A; Powe T; Chakravarty E; Alberola-Ila J
    Clin Exp Immunol; 2016 Nov; 186(2):214-226. PubMed ID: 27513522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
    Ouaissi A; Ouaissi M
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunopathogenesis of Leishmania infections].
    Yurdakul P
    Mikrobiyol Bul; 2005 Jul; 39(3):363-81. PubMed ID: 16358498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.
    Duarte MC; Lage DP; Martins VT; Costa LE; Carvalho AMRS; Ludolf F; Santos TTO; Vale DL; Roatt BM; Menezes-Souza D; Fernandes AP; Tavares CAP; Coelho EAF
    Immunobiology; 2017 Feb; 222(2):251-260. PubMed ID: 27693018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulator and effector functions of T-cell subsets in human Leishmania infections.
    Kemp M
    APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmaniasis and various immunotherapeutic approaches.
    Taslimi Y; Zahedifard F; Rafati S
    Parasitology; 2018 Apr; 145(4):497-507. PubMed ID: 27974063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells.
    Tripp CH; Sparber F; Hermans IF; Romani N; Stoitzner P
    J Immunol; 2009 Jun; 182(12):7644-54. PubMed ID: 19494288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly.
    Novais FO; Scott P
    Semin Immunopathol; 2015 May; 37(3):251-9. PubMed ID: 25800274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.